- Home
- CYCC vs EKSO Comparison
CYCC vs EKSO Comparison
Compare CYCC & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- EKSO
- Stock Information
- Founded
- CYCC 1992
- EKSO 2005
- Country
- CYCC Malaysia
- EKSO United States
- Employees
- CYCC N/A
- EKSO N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- CYCC Health Care
- EKSO Health Care
- Exchange
- CYCC Nasdaq
- EKSO Nasdaq
- Market Cap
- CYCC 7.8M
- EKSO 7.7M
- IPO Year
- CYCC N/A
- EKSO N/A
- Fundamental
- Price
- CYCC $16.04
- EKSO $4.82
- Analyst Decision
- CYCC
- EKSO Strong Buy
- Analyst Count
- CYCC 0
- EKSO 2
- Target Price
- CYCC N/A
- EKSO $37.50
- AVG Volume (30 Days)
- CYCC 5.3M
- EKSO 105.4K
- Earning Date
- CYCC 08-13-2025
- EKSO 07-28-2025
- Dividend Yield
- CYCC N/A
- EKSO N/A
- EPS Growth
- CYCC N/A
- EKSO N/A
- EPS
- CYCC N/A
- EKSO N/A
- Revenue
- CYCC $14,000.00
- EKSO $17,544,000.00
- Revenue This Year
- CYCC $137.21
- EKSO $0.20
- Revenue Next Year
- CYCC N/A
- EKSO $42.29
- P/E Ratio
- CYCC N/A
- EKSO N/A
- Revenue Growth
- CYCC N/A
- EKSO N/A
- 52 Week Low
- CYCC $3.08
- EKSO $2.73
- 52 Week High
- CYCC $597.60
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- CYCC 60.33
- EKSO 69.09
- Support Level
- CYCC $10.05
- EKSO $3.79
- Resistance Level
- CYCC $19.87
- EKSO $4.28
- Average True Range (ATR)
- CYCC 3.57
- EKSO 0.35
- MACD
- CYCC 1.99
- EKSO 0.21
- Stochastic Oscillator
- CYCC 77.07
- EKSO 98.82
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.